Xu Yuan

Insider profile

Xu Yuan's trades of Fate Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
383.57
Quantity 28,145 +24.9%
Value US$245,796
Transaction date
Proposed sale
Price
284.44
Quantity 29,591
Value US$3,391,969
Transaction date
Planned sale
Price
456.64
Quantity 25,668 +13.2%
Value US$4,712,142
Transaction date
Proposed sale
Price
3.71
Quantity 632
Value US$2,345
Transaction date
Proposed sale
Price
5.58
Quantity 3,460
Value US$19,307
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-07 2024-08-06 PlS Planned sale
28,145 +24.9%
383.57
US$245,796
28,145 +24.9% 383.57 US$245,796
2024-08-06 2024-08-06 PrS Proposed sale
29,591
284.44
US$3,391,969
29,591 284.44 US$3,391,969
2023-08-07 2023-08-04 PlS Planned sale
25,668 +13.2%
456.64
US$4,712,142
25,668 +13.2% 456.64 US$4,712,142
2023-08-04 2023-08-04 PrS Proposed sale
632
3.71
US$2,345
632 3.71 US$2,345
2023-06-15 2023-06-14 PlS Planned sale
3,460 -25.8%
5.58
US$19,307
3,460 -25.8% 5.58 US$19,307
2023-06-14 2023-06-14 PrS Proposed sale
3,460
5.58
US$19,307
3,460 5.58 US$19,307